Market Research Reports

Categories

Countries

Pharmaceuticals Reports

India Tetracycline Market By Product Type (OTC, Prescription), By Type (Tetracycline Hydrochloride, Tetracycline Phosphate), By Source (In-house, Contract Manufacturing Organizations), By Form (Tablet, Capsule, Powder, Ointments, Injection, Others), By Distribution Channel (Online, Offline), By Application (Respiratory, Bowel, Genital, Systemic Infections, Others), By Route of Administration (Oral, Topical, Ophthalmic), By Region, Competition, Forecast & Opportunities, 2021-2031F

Growth in the Veterinary Sector and Increasing Incidence of Infectious Diseases are factors driving the India Tetracycline market in the forecast period Read More

India Clinical Trials Market By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Autoimmune, Blood Disorders, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Growing demand for clinical trials and high R&D expenditure of the pharmaceutical industry are factors driving the India Clinical Trials Market in the forecast Read More

India Immunology Drugs Market By Drug Class (Monoclonal Antibodies (mAb), Antibody Drug Conjugates, Interferon and Cytokine therapies, Immunosuppressive medication, Others), By Indication (Arthritis, Plaque Psoriasis, Spondylitis, Inflammatory Bowel Disease, Transplant Rejection, Others), By End User (Hospitals & Clinics, Cancer Research Institute, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Rising burden of chronic diseases and increasing focus on targeted therapies are factors driving the India Immunology Drugs Market in the forecast period Read More

India Over The Counter Drugs Market By Product Type (Cold, Cough & Flu, Vitamins, Minerals & Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others), By Route of Administration (Oral, Parenteral, Topical, Others), By Dosage Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast & Opportunities, 2021-2031F

Launch of new OTC products and increasing awareness for self-medication are factors driving the India Over The Counter Drugs Market in the forecast period Read More

India Lopinavir & Ritonavir Market By Dosage Form (Tablet, Capsule, Oral Solution), By Dosage (Lopinavir 200mg/ Ritonavir 50mg Co-formulated Tablet, Lopinavir 100mg/ Ritonavir-25mg Co-formulated Capsule, Lopinavir 400mg/ Ritonavir 100mg/ 10ml Oral Solution), By Application (HIV, COVID-19, Hepatitis C, Others), By Distribution Channel (Hospitals & Clinics, Drug Stores/Pharmacies, Online, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Rise in the prevalence of HIV/AIDS and growing government initiatives are factors driving the India Lopinavir & Ritonavir Market in the forecast period 2027-2031.Read More

Global Xerostomia (Dry Mouth Disease) Therapeutics Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, By Therapeutic Modality (Artificial Saliva / Saliva Substitutes, Salivary Stimulants, Electro-stimulation Devices, Other Therapeutic Modalities), By Product Form (Sprays, Gels, Lozenges / Pastilles, Mouthwashes / Rinses, Other Product Forms), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, By Company 2021-2031F

The Global Xerostomia (Dry Mouth Disease) Therapeutics Market is expected to grow from USD 1.84 Billion in 2025 to USD 2.33 Billion by 2031 at a 4.0% CAGRRead More

Global Yersiniosis Diagnostics and Treatment Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, By Bacterial Species (Yersinia enterocolitica, Yersinia pseudotuberculosis), By Product Type (Diagnosis Technique, Real-Time PCR, ELISA, Immunoassay, Protein Microarray, Stool Culture, Other Diagnosis Technique, Therapeutics, Aminoglycosides, Sulfonamides, Cephalosporins, Fluoroquinolones, Tetracyclines, Other Therapeutics), By Region, By Company 2021-2031F

The Global Yersiniosis Diagnostics and Treatment Market is expected to grow from USD 0.0 Billion in 2025 to USD 0.0 Billion by 2031 at a 6.77% CAGRRead More

Global Yellow Fever Treatment Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, By Treatment Type (Live-attenuated Vaccines, Inactivated / Recombinant Vaccines, Antiviral Therapeutics (Investigational), Supportive Care Drugs & Consumables), By Route of Administration (Subcutaneous Injection, Intramuscular Injection, Intradermal Jet Injection), By Distribution Channel (Government Procurement Agencies, International Agencies (UNICEF, PAHO), Retail & Online Pharmacies), By Age Group (Paediatric (9 m – 15 y), Adult (16 – 60 y), Geriatric ( More Than 60 y)), By Region, By Company 2021-2031F

The Global Yellow Fever Treatment Market is expected to grow from USD 395.65 Million in 2025 to USD 506.14 Million by 2031 at a 4.19% CAGRRead More

Global Hairy Cell Leukemia Treatment Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, By Treatment Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Antimalarials, Corticosteroids, Immunosuppressants / DMARDs, Biologics, Stem-cell & Gene-based Therapies), By Route of Administration (Oral, Intravenous, Subcutaneous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, By Company 2021-2031F

The Global Hairy Cell Leukemia Treatment Market is expected to grow from USD 124.63 Million in 2025 to USD 175.39 Million by 2031 at a 5.86% CAGRRead More

Global Halal Empty Capsules Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, By Type (Gelatin Empty Capsules, Non-Gelatin Empty Capsules), By Application (Pharmaceuticals, Nutraceuticals, Dietary, Other Applications), By End User (Pharmaceutical, Nutraceutical, Other End Users), By Distribution Channel (Direct Sales, Wholesalers, Online Platforms, Others), By Region, By Company 2021-2031F

The Global Halal Empty Capsules Market is expected to grow from USD 1.43 Billion in 2025 to USD 1.96 Billion by 2031 at a 5.37% CAGRRead More

Global Celiac Disease Treatment Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, By Drug Class (Vitamin & Mineral Supplements, Steroids & Immuno-suppressive Drugs, Enzyme-based Therapies, Tight-Junction Modulators, Tolerance-Inducing Immunotherapies, Others), By Disease Type (Classical CD, Non-Responsive CD, Refractory CD (Type I & II), Asymptomatic / Silent CD), By Line of Therapy (First Line, Second Line), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region, By Company 2021-2031F

The Global Celiac Disease Treatment Market is expected to grow from USD 673.39 Million in 2025 to USD 966.08 Million by 2031 at a 6.2% CAGRRead More

Global Cardiac Safety Service Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, By Service Type (Thorough QT/QTc Study Services, ECG & Holter Monitoring Analysis, Blood Pressure & Telemetry Analysis, Cardiovascular Imaging (Echocardiography, MUGA), Real-Time Data Analytics & Reporting), By Service Delivery Model (In-house (Sponsor-run), Outsourced (CRO & Specialist Vendors)), By Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV / Post-marketing), By End User (Pharmaceutical Companies, Biotechnology Firms, Medical Device Manufacturers, Contract Research Organisations (CROs)), By Region, By Company 2021-2031F

The Global Cardiac Safety Service Market is expected to grow from USD 0.94 Billion in 2025 to USD 1.76 Billion by 2031 at a 11.03% CAGRRead More

Global Cardiogenic Shock Treatment Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, By Product Type (Pharmacological Therapy, Inotropes, Vasopressors, Mechanical Circulatory Support Devices, Intra-aortic Balloon Pump (IABP), Percutaneous Ventricular Assist Devices (Impella), Extracorporeal Membrane Oxygenation (ECMO), Surgical Ventricular Assist Devices (LVAD, RVAD, BiVAD), Revascularisation Procedures, Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting (CABG)), By Severity Stage (SCAI) (Stage A – At Risk, Stage B – Beginning Shock, Stage C – Classic Shock, Stage D – Deteriorating, Stage E – Extremis), By Etiology (Acute Myocardial Infarction, Non-Ischaemic Cardiomyopathy, Post-Cardiotomy, Fulminant Myocarditis, Others), By End User (Tertiary-Care Hospitals, Cardiac Catheterisation Labs, Ambulatory Surgical Centres, Others), By Region, By Company 2021-2031F

The Global Cardiogenic Shock Treatment Market is expected to grow from USD 1.1 Billion in 2025 to Not 1.68 in the provided page by 2031 at a 7.31% CAGRRead More

Global Cardiovascular Drugs Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, By Drug Class (Anticoagulants, Heart-failure drugs, Antihypertensives, Lipid-lowering agents, Pulmonary-hypertension drugs, Antiarrhythmics), By Disease Indication (Hypertension, Heart failure, Coronary-artery disease (CAD), Dyslipidemia), By Route of Administration (Oral, Injectable (incl. Injectable / IV)), By Distribution Channel (Hospitals / Hospital pharmacies, Pharmacies / Online pharmacies, More (Other distribution)), By Region, By Company 2021-2031F

The Global Cardiovascular Drugs Market is expected to grow from USD 159.59 Billion in 2025 to USD 193.69 Billion by 2031 at a 3.28% CAGRRead More

Global Non-Alcoholic Fatty Liver Disease (NAFLD) Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, By Drug Class (2025 Share) (Antioxidants (28.45%), FXR Agonists), By Distribution Channel (2025 Share) (Hospital Pharmacies (47.32%), Online Pharmacies), By Route of Administration (2025 Share) (Oral Formulations (67.10%), Parenteral Products), By Age Group (Adults (64.72%), Geriatric Segment), By Region, By Company 2021-2031F

The Global Non-Alcoholic Fatty Liver Disease (NAFLD) Market is expected to grow from USD 17.47 Billion in 2025 to USD 41.93 Billion by 2031 at a 15.71% CAGRRead More

Global Non-alcoholic Steatohepatitis Therapeutics And Diagnostics Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, By Solution (Value) (Therapeutics, By Drug Class, FXR Agonists, THR-ß Agonists, GLP-1 Agonists, Others, Diagnostics, By Diagnostic Modality, Imaging Tests, Biomarker-based Blood Tests, Liver Biopsy, Elastography), By End User (Value) (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, Others), By Region, By Company 2021-2031F

The Global Non-alcoholic Steatohepatitis Therapeutics And Diagnostics Market is expected to grow from USD 5.78 Billion in 2025 to USD 15.78 Billion by 2031 at a Read More

Global Non-Hodgkin Lymphoma Therapeutics Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, By Therapy Type (Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy (incl. CAR-T, Bispecifics), Other Therapies), By Cell Type (B-cell Lymphomas, T-cell Lymphomas), By Treatment Line (First-line, Second-line, Third-line & Refractory), By Region, By Company 2021-2031F

The Global Non-Hodgkin Lymphoma Therapeutics Market is expected to grow from USD 11.09 Billion in 2025 to USD 16.58 Billion by 2031 at a 6.93% CAGRRead More

Brazil Retail Pharmacy Market, By Product (Prescription, OTC), By Type (Chain, Independent, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Aging Population and Chronic Disease Prevalence and Government Support and Regulatory Framework are factors driving the Brazil Retail Pharmacy market in the Read More

Egypt Pharmaceutical Market By Type (Pharmaceutical Drugs and Biologics), By Drug Classification (Branded Drugs and Generic Drugs), By Mode of Purchase (Prescription-Based Drugs and Over-the-counter Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, By Competition, Forecast & Opportunities, 2021-2031F

Investment in pharmaceutical infrastructure and increasing prevalence of chronic diseases is expected to drive the Egypt Pharmaceutical Market growth in the Read More

Kenya Pharmaceutical Market By Drug Type (Generic Drugs, Branded Drugs), By Product Type (Prescription Drugs, Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast & Opportunities, 2021-2031F

Growing Population and Urbanization and Evolving Disease Profiles are factors driving the Kenya Pharmaceutical market in the forecast period 2026-2030.Read More


   Page 1 of 30 Next